These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19417014)

  • 1. Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.
    Vail DM; Thamm DH; Reiser H; Ray AS; Wolfgang GH; Watkins WJ; Babusis D; Henne IN; Hawkins MJ; Kurzman ID; Jeraj R; Vanderhoek M; Plaza S; Anderson C; Wessel MA; Robat C; Lawrence J; Tumas DB
    Clin Cancer Res; 2009 May; 15(10):3503-10. PubMed ID: 19417014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma.
    Reiser H; Wang J; Chong L; Watkins WJ; Ray AS; Shibata R; Birkus G; Cihlar T; Wu S; Li B; Liu X; Henne IN; Wolfgang GH; Desai M; Rhodes GR; Fridland A; Lee WA; Plunkett W; Vail D; Thamm DH; Jeraj R; Tumas DB
    Clin Cancer Res; 2008 May; 14(9):2824-32. PubMed ID: 18451250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of 3'-deoxy-3'-[18F]fluorothymidine PET/CT for evaluating response to cytotoxic chemotherapy in dogs with non-Hodgkin's lymphoma.
    Lawrence J; Vanderhoek M; Barbee D; Jeraj R; Tumas DB; Vail DM
    Vet Radiol Ultrasound; 2009; 50(6):660-8. PubMed ID: 19999354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanovea® for the treatment of lymphoma in dogs.
    De Clercq E
    Biochem Pharmacol; 2018 Aug; 154():265-269. PubMed ID: 29778492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma.
    Thamm DH; Vail DM; Kurzman ID; Babusis D; Ray AS; Sousa-Powers N; Tumas DB
    BMC Vet Res; 2014 Jan; 10():30. PubMed ID: 24460928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma.
    Thamm DH; Vail DM; Post GS; Fan TM; Phillips BS; Axiak-Bechtel S; Elmslie RS; Klein MK; Ruslander DA
    J Vet Intern Med; 2017 May; 31(3):872-878. PubMed ID: 28370378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses.
    Saba CF; Vickery KR; Clifford CA; Burgess KE; Phillips B; Vail DM; Wright ZM; Morges MA; Fan TM; Thamm DH
    Vet Comp Oncol; 2018 Mar; 16(1):E76-E82. PubMed ID: 28891260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acyclic nucleoside phosphonates as potential antineoplastic agents].
    Votruba I; Otová B; Holý A
    Cas Lek Cesk; 2008; 147(9):471-7. PubMed ID: 18988489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the oral antimitotic agent (ABT-751) in dogs with lymphoma.
    Silver M; Rusk A; Phillips B; Beck E; Jankowski M; Philibert J; Hahn K; Hershey E; McKeegan E; Bauch J; Krivoshik A; Khanna C
    J Vet Intern Med; 2012; 26(2):349-54. PubMed ID: 22369215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma.
    Rusk A; Cozzi E; Stebbins M; Vail D; Graham J; Valli V; Henkin J; Sharpee R; Khanna C
    Clin Cancer Res; 2006 Dec; 12(24):7456-64. PubMed ID: 17189419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
    Herrmann K; Wieder HA; Buck AK; Schöffel M; Krause BJ; Fend F; Schuster T; Meyer zum Büschenfelde C; Wester HJ; Duyster J; Peschel C; Schwaiger M; Dechow T
    Clin Cancer Res; 2007 Jun; 13(12):3552-8. PubMed ID: 17575218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell lines.
    Lawrence JA; Huelsmeyer MK; Thamm DH; Tumas DB; Birkus G; Kurzman I; Vail DM
    Vet Comp Oncol; 2015 Sep; 13(3):246-54. PubMed ID: 23672437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
    Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
    Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
    Witzig TE; Wiernik PH; Moore T; Reeder C; Cole C; Justice G; Kaplan H; Voralia M; Pietronigro D; Takeshita K; Ervin-Haynes A; Zeldis JB; Vose JM
    J Clin Oncol; 2009 Nov; 27(32):5404-9. PubMed ID: 19805688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma.
    Morges MA; Burton JH; Saba CF; Vail DM; Burgess KE; Thamm DH
    J Vet Intern Med; 2014; 28(5):1569-74. PubMed ID: 25274443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    la Fougère C; Hundt W; Bröckel N; Pfluger T; Haug A; Scher B; Hacker M; Hahn K; Reiser M; Tiling R
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1417-25. PubMed ID: 16858568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.
    Torizuka T; Nakamura F; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Kobayashi M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):22-8. PubMed ID: 14574514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J
    Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; van Heerde P; Misdorp W
    Eur J Cancer; 1990; 26(8):891-5. PubMed ID: 2145933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.